AbbVie Inc. (ABBV) Presents at Leerink Global Healthcare Conference 2026 Transcript

Growth Prospects - The company is optimistic about its growth prospects, projecting a revenue of $67 billion for 2026 and maintaining high single-digit growth through the decade [2] - There is confidence in the portfolio of assets that are currently in place, which are considered market derisked, supporting robust growth into the next decade [2] Margin Profile - The company has a clear strategy to drive growth, with a focus on key products like SKYRIZI, which is expected to contribute significantly to the overall growth trajectory [2]